The International Directory of Biotechnology Companies 2009 is one of the most comprehensive and accurate Directory of companies and executives in the biotechnology industry that have ever been published. It contains more than 3,000 biotechnology companies and 10,000 executives working in the industry around the world.

This powerful Directory is your connection to key decision-makers in the biotechnology industry in Europe, the Americas, the Asia & Pacific region, the Middle East and Africa.

No other international directory keeps you abreast of the thousands of personnel changes taking place due to company mergers, acquisitions, consolidations, and staff turnover. This Directory is a must-have for anyone who needs to find contacts in the biotechnology worldwide.

This Directory will enable you to:

• Pinpoint key executives
• Profile a market
• Build new business prospects
• Generate new customers
• Discover who your competitors are
• Make vital contacts
• Save the time, money and effort of doing your own research
• Identify alternative suppliers and manufacturers
• Source up-to-date company information
• Keep track of key staff movements
• Access a wealth of quality information on companies and key personnel worldwide.

Whether you are a product manager, in charge of marketing or simply interested to remain in touch with the latest developments in the biotechnology industry, this Directory will save you time and effort in finding the up-to-date information you need.

Company categories include in this Directory include:

• Biotechnology
• Genomics
• Biopharmaceuticals
• Gene Mapping
• Bioinformatics
• Gene Sequencing
• Biochips
• Pharmacogenomics & SNP’s
• Functional Genomics
• plus many more categories!

This Directory also covers senior personnel in key job function areas such as:

• Managing Directors/CEOs
• Strategy & Planning
• Directors
• Market Research
• Senior Management
• Regulatory & Legal Affairs
• Sales & Marketing
• Personnel
• Research & Development
• Business Development
• and much more!

Key Features of the Directory include:

• 3,000 biotechnology companies listed with description of company activities
• 10,000 senior biotechnology personnel listed with name & job title
• Full contact details including email and website addresses
• Global coverage of companies and key personnel
• Comprehensive Indexing

Coverage:

• Western & Eastern Europe incl. UK
• USA & Canada
• South & Central America
• The Middle East
• Africa
• East, South & North Asia incl. Japan
• Australasia and the Pacific

This Directory has been especially compiled to assist biotechnology professionals with market research, strategic planning, as well as contacting prospective clients or suppliers. It is also an indispensable guide to all of the world’s biotechnology companies and key biotechnology decision makers!

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1195/International-Directory-of-Biotechnology-Companies-2010.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

Summary

The latest research, “Small and Medium Biopharmaceutical Enterprises in North America and Europe – Biotech Clusters, Funding Characteristics and Regulatory Landscape” report provides an overview of the small and medium biopharmaceutical enterprises in the North American and European regions. The report provides an insight in to the importance of Small and Medium Enterprises (SME) in the biotechnology industry. It covers market characterization, geographical spread of SMEs, drivers and restraints, regulatory scenarios and funding challenges faced by the biotechnology SME industry. The study reviews the role of SMEs in driving the pipeline within the biotechnology industry, the role of governments in promoting the sector, as well as potential gaps. It provides a comprehensive analysis of the deals in the SME sector and also provides competitive benchmarking to understand how SMEs compete.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

The scope of this report includes :
- Biotechnology SME composition in North America, and Europe. In North America, the US (United States) and Canada are covered. The report covers European countries such as the UK (United Kingdom), Germany, Canada, France, Sweden, Switzerland, Denmark, the Netherlands and Belgium.
- Pipeline analysis data for the two geographies to provide an understanding of the contribution of biotechnology SMEs in the pipeline of the industry.
- Qualitative analysis of market drivers and restraints and funding for SMEs. Funding structure for biotechnology SMEs and issues faced in funding.
- Analysis of deals involving biotechnology SMEs.
- Competitive landscape covering key players Clovis Oncology, Pacific Biosciences, ActoGeniX, Aileron, BioVex, AC Immune, Avila Therapeutics, Chroma Therapeutics, KaloBios, Achaogen.

Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to :
- Develop an understanding of the SME biotechnology sector and the role played by them in driving innovation in the pharmaceutical and biotechnology industries.
- Understand the funding related issues that SMEs face and make use of the potential solutions.
- Exploit in-licensing and out-licensing opportunities by identifying the key areas of licensing activities of SME biotechnology firms.
- Understand and exploit M&A opportunities present in the biotechnology SME landscape.
- Develop a clear knowledge & understanding of how SMEs are supported in North America and Europe.
- Identify key players best positioned to take advantage of the emerging market opportunities.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1482/Small-and-Medium-Biopharmaceutical-Enterprises-in-North-America-and-Europe-Biotechnology-Clusters-Funding-Characteristics-and-Regulatory-Landscape.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

Summary

The leading business intelligence provider, has released its latest research, “Top 10 Biotechnology Companies – SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline”, which provides an insight into the global biotechnology industry and analyzes the competitive positioning of the top 10 companies in the industry. This pharmaceutical and healthcare report estimates the market size of the global biotechnology industry and its future prospects. It benchmarks the leading companies in the biotechnology industry on selected parameters to analyze their competitive positioning in the market. The report analyzes the future landscape of the biotechnology industry by forecasting the revenues of leading companies to 2012. For each company the report analyzes the financial strength, product portfolio, pipeline strength and therapeutic focus of its R&D activities. It critically examines the strengths and weaknesses of individual companies and the opportunities and threats facing them.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

The report analyses the competitive landscape of the biotechnology industry, R&D strategies and pipeline of the top 10 players, and strengths, weaknesses, opportunities and threats facing these companies. Its scope includes
- Market size of the global biotechnology industry and coverage of the changing competitive landscape from 2008 to 2012.
- Review of key industry drivers and restraints which are likely to impact the global biotechnology industry in the future.
- Analysis of the competitive positioning of the top 10 biotechnology companies globally.
- Analysis of pipeline products in the global biotech market by therapy area like cancer, infectious diseases, respiratory disorders, autoimmune disorders, and product classes.
- Financial analysis including annual revenues of top 10 companies from 2004 to 2008, with forecasts to 2012.
- SWOT analysis, DuPont analysis and financial benchmarking of the top 10 biotech companies.
- Analysis of the therapeutic focus, marketed products and product pipeline of top 10 biotech companies.

Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
- Develop a clear knowledge and understanding of the competitive landscape and how this will change in the coming years.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Effectively plan your M&A and partnership strategies by identifying companies with the most promising pipeline.
- Make more informed business decisions from the insightful and in-depth analysis of the key strategies to be followed by competitors.
- Effectively plan your investment strategies by identifying companies with maximum investment potential.
- Identify key winners and losers and who is best positioned to take advantage of the emerging market opportunities.

Companies Mentioned

Amgen
Genentech (Roche)
Gilead Sciences
UCB Pharma
Genzyme
Biogen Idec
CSL Limited
Celgene
Cephalon
Actelion

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1208/Top-10-Biotechnology-Companies-SWOT-Analysis-Competitive-Benchmarking-Financial-Analysis-and-R-D-Pipeline.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com